KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to $42.4 million.

  • Novavax's Cash from Financing Activities rose 4385463.92% to $42.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.9 million, marking a year-over-year decrease of 9151.5%. This contributed to the annual value of $260.6 million for FY2024, which is 573481.86% up from last year.
  • Latest data reveals that Novavax reported Cash from Financing Activities of $42.4 million as of Q3 2025, which was up 4385463.92% from -$1.0 million recorded in Q2 2025.
  • Over the past 5 years, Novavax's Cash from Financing Activities peaked at $577.0 million during Q1 2021, and registered a low of -$354.4 million during Q1 2023.
  • In the last 5 years, Novavax's Cash from Financing Activities had a median value of $4.7 million in 2022 and averaged $57.2 million.
  • Per our database at Business Quant, Novavax's Cash from Financing Activities crashed by 32167.39% in 2023 and then soared by 4385463.92% in 2025.
  • Novavax's Cash from Financing Activities (Quarter) stood at -$60.7 million in 2021, then surged by 415.33% to $191.4 million in 2022, then crashed by 47.56% to $100.4 million in 2023, then tumbled by 103.41% to -$3.4 million in 2024, then skyrocketed by 1340.27% to $42.4 million in 2025.
  • Its last three reported values are $42.4 million in Q3 2025, -$1.0 million for Q2 2025, and -$7.1 million during Q1 2025.